<!-- Elements added to main will be displayed on all pages --> <!doctype html><html lang=en class=no-js> <head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta name=description content="CRGH Department of Immunology"><meta name=author content="Ramon Yuson"><link href=https://immunowiki.com/protocols/venom-immunotherapy/ rel=canonical><link rel=icon href=../../assets/images/favicon.png><meta name=generator content="mkdocs-1.3.0, mkdocs-material-8.2.15+insiders-4.15.1"><title>Venom immunotherapy - Immunowiki</title><link rel=stylesheet href=../../assets/stylesheets/main.6cd88726.min.css><link rel=stylesheet href=../../assets/stylesheets/palette.96b5c56e.min.css><link rel=stylesheet href="../../assets/externals/fonts.googleapis.com/css.css"><style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style><link rel=stylesheet href=../../stylesheets/extra.css><script>__md_scope=new URL("../..",location),__md_hash=e=>[...e].reduce((e,_)=>(e<<5)-e+_.charCodeAt(0),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script></head> <body dir=ltr data-md-color-scheme=default data-md-color-primary=indigo data-md-color-accent=indigo> <script>var palette=__md_get("__palette");if(palette&&"object"==typeof palette.color)for(var key of Object.keys(palette.color))document.body.setAttribute("data-md-color-"+key,palette.color[key])</script> <input class=md-toggle data-md-toggle=drawer type=checkbox id=__drawer autocomplete=off> <input class=md-toggle data-md-toggle=search type=checkbox id=__search autocomplete=off> <label class=md-overlay for=__drawer></label> <div data-md-component=skip> <a href=#modified-rush-protocol-for-venom-immunotherapy class=md-skip> Skip to content </a> </div> <div data-md-component=announce> <aside class=md-banner> <div class="md-banner__inner md-grid md-typeset"> <button class="md-banner__button md-icon" aria-label="Don't show this again"> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg> </button> This website contains general medical information which is not advice and should not be treated as such. </div> <script>var content,el=document.querySelector("[data-md-component=announce]");el&&(content=el.querySelector(".md-typeset"),__md_hash(content.innerHTML)===__md_get("__announce")&&(el.hidden=!0))</script> </aside> </div> <header class=md-header data-md-component=header> <nav class="md-header__inner md-grid" aria-label=Header> <a href=../.. title=Immunowiki class="md-header__button md-logo" aria-label=Immunowiki data-md-component=logo> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M13 12h7v1.5h-7m0-4h7V11h-7m0 3.5h7V16h-7m8-12H3a2 2 0 0 0-2 2v13a2 2 0 0 0 2 2h18a2 2 0 0 0 2-2V6a2 2 0 0 0-2-2m0 15h-9V6h9"/></svg> </a> <label class="md-header__button md-icon" for=__drawer> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2Z"/></svg> </label> <div class=md-header__title data-md-component=header-title> <div class=md-header__ellipsis> <div class=md-header__topic> <span class=md-ellipsis> Immunowiki </span> </div> <div class=md-header__topic data-md-component=header-topic> <span class=md-ellipsis> Venom immunotherapy </span> </div> </div> </div> <form class=md-header__option data-md-component=palette> <input class=md-option data-md-color-media data-md-color-scheme=default data-md-color-primary=indigo data-md-color-accent=indigo aria-label="Switch to dark mode" type=radio name=__palette id=__palette_1> <label class="md-header__button md-icon" title="Switch to dark mode" for=__palette_2 hidden> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6zm0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4zM7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg> </label> <input class=md-option data-md-color-media data-md-color-scheme=slate data-md-color-primary=indigo data-md-color-accent=indigo aria-label="Switch to light mode" type=radio name=__palette id=__palette_2> <label class="md-header__button md-icon" title="Switch to light mode" for=__palette_1 hidden> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3Z"/></svg> </label> </form> <label class="md-header__button md-icon" for=__search> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg> </label> <div class=md-search data-md-component=search role=dialog> <label class=md-search__overlay for=__search></label> <div class=md-search__inner role=search> <form class=md-search__form name=search> <input type=text class=md-search__input name=query aria-label=Search placeholder=Search autocapitalize=off autocorrect=off autocomplete=off spellcheck=false data-md-component=search-query required> <label class="md-search__icon md-icon" for=__search> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg> </label> <nav class=md-search__options aria-label=Search> <a href=javascript:void(0) class="md-search__icon md-icon" aria-label=Share data-clipboard data-clipboard-text data-md-component=search-share tabindex=-1> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M18 16.08c-.76 0-1.44.3-1.96.77L8.91 12.7c.05-.23.09-.46.09-.7 0-.24-.04-.47-.09-.7l7.05-4.11c.54.5 1.25.81 2.04.81a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3c0 .24.04.47.09.7L8.04 9.81C7.5 9.31 6.79 9 6 9a3 3 0 0 0-3 3 3 3 0 0 0 3 3c.79 0 1.5-.31 2.04-.81l7.12 4.15c-.05.21-.08.43-.08.66 0 1.61 1.31 2.91 2.92 2.91 1.61 0 2.92-1.3 2.92-2.91A2.92 2.92 0 0 0 18 16.08Z"/></svg> </a> <button type=reset class="md-search__icon md-icon" aria-label=Clear tabindex=-1> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg> </button> </nav> <div class=md-search__suggest data-md-component=search-suggest></div> </form> <div class=md-search__output> <div class=md-search__scrollwrap data-md-scrollfix> <div class=md-search-result data-md-component=search-result> <div class=md-search-result__meta> Initializing search </div> <ol class=md-search-result__list></ol> </div> </div> </div> </div> </div> </nav> </header> <div class=md-container data-md-component=container> <nav class=md-tabs aria-label=Tabs data-md-component=tabs> <div class="md-tabs__inner md-grid"> <ul class=md-tabs__list> <li class=md-tabs__item> <a href=../.. class=md-tabs__link> Home </a> </li> <li class=md-tabs__item> <a href=../../forms/ class=md-tabs__link> Forms </a> </li> <li class=md-tabs__item> <a href=../../allergy/food-allergy/allergen-cards/ class=md-tabs__link> Allergy </a> </li> <li class=md-tabs__item> <a href=../../assets/qr/i/ class=md-tabs__link> Assets </a> </li> <li class=md-tabs__item> <a href=../../checklists/clinical-allergen-challenge/ class=md-tabs__link> Checklists </a> </li> <li class=md-tabs__item> <a href=../../patient-information/acute-urticaria/ class=md-tabs__link> Patient information </a> </li> <li class=md-tabs__item> <a href=../alutek-immunotherapy/ class="md-tabs__link md-tabs__link--active"> Protocols </a> </li> </ul> </div> </nav> <main class=md-main data-md-component=main> <div class="md-main__inner md-grid"> <div class="md-sidebar md-sidebar--primary" data-md-component=sidebar data-md-type=navigation> <div class=md-sidebar__scrollwrap> <div class=md-sidebar__inner> <nav class="md-nav md-nav--primary md-nav--lifted" aria-label=Navigation data-md-level=0> <label class=md-nav__title for=__drawer> <a href=../.. title=Immunowiki class="md-nav__button md-logo" aria-label=Immunowiki data-md-component=logo> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M13 12h7v1.5h-7m0-4h7V11h-7m0 3.5h7V16h-7m8-12H3a2 2 0 0 0-2 2v13a2 2 0 0 0 2 2h18a2 2 0 0 0 2-2V6a2 2 0 0 0-2-2m0 15h-9V6h9"/></svg> </a> Immunowiki </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../.. class=md-nav__link> <span class=md-ellipsis> Home </span> </a> </li> <li class=md-nav__item> <a href=../../forms/ class=md-nav__link> <span class=md-ellipsis> Forms </span> </a> </li> <li class="md-nav__item md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_3 type=checkbox id=__nav_3> <label class=md-nav__link for=__nav_3> <span class=md-ellipsis> Allergy </span> <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label=Allergy data-md-level=1> <label class=md-nav__title for=__nav_3> <span class="md-nav__icon md-icon"></span> Allergy </label> <ul class=md-nav__list data-md-scrollfix> <li class="md-nav__item md-nav__item--section md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_3_1 type=checkbox id=__nav_3_1> <label class=md-nav__link for=__nav_3_1> <span class=md-ellipsis> Food allergy </span> <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label="Food allergy" data-md-level=2> <label class=md-nav__title for=__nav_3_1> <span class="md-nav__icon md-icon"></span> Food allergy </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../allergy/food-allergy/allergen-cards/ class=md-nav__link> <span class=md-ellipsis> Allergen Cards </span> </a> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--section md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_3_2 type=checkbox id=__nav_3_2> <label class=md-nav__link for=__nav_3_2> <span class=md-ellipsis> Protocols </span> <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label=Protocols data-md-level=2> <label class=md-nav__title for=__nav_3_2> <span class="md-nav__icon md-icon"></span> Protocols </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../allergy/protocols/steroid-skin-testing/ class=md-nav__link> <span class=md-ellipsis> Steroid Testing </span> </a> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--section md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_3_3 type=checkbox id=__nav_3_3> <label class=md-nav__link for=__nav_3_3> <span class=md-ellipsis> Venoms </span> <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label=Venoms data-md-level=2> <label class=md-nav__title for=__nav_3_3> <span class="md-nav__icon md-icon"></span> Venoms </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../allergy/venoms/letter-to-gp/ class=md-nav__link> <span class=md-ellipsis> Letter to GP </span> </a> </li> <li class=md-nav__item> <a href=../../allergy/venoms/modified-rush-protocol/ class=md-nav__link> <span class=md-ellipsis> Appendix B - Modified Rush Protocol </span> </a> </li> <li class=md-nav__item> <a href=../../allergy/venoms/standard-initiation-protocol/ class=md-nav__link> <span class=md-ellipsis> Appendix A - Standard Initiation Protocol </span> </a> </li> <li class=md-nav__item> <a href=../../allergy/venoms/venom-allergy-testing/ class=md-nav__link> <span class=md-ellipsis> Venom Allergy Testing </span> </a> </li> <li class=md-nav__item> <a href=../../allergy/venoms/venom-immunotherapy-desensitisation/ class=md-nav__link> <span class=md-ellipsis> Venom Immunotherapy / Desensitisation </span> </a> </li> </ul> </nav> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_4 type=checkbox id=__nav_4> <label class=md-nav__link for=__nav_4> <span class=md-ellipsis> Assets </span> <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label=Assets data-md-level=1> <label class=md-nav__title for=__nav_4> <span class="md-nav__icon md-icon"></span> Assets </label> <ul class=md-nav__list data-md-scrollfix> <li class="md-nav__item md-nav__item--section md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_4_1 type=checkbox id=__nav_4_1> <label class=md-nav__link for=__nav_4_1> <span class=md-ellipsis> Qr </span> <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label=Qr data-md-level=2> <label class=md-nav__title for=__nav_4_1> <span class="md-nav__icon md-icon"></span> Qr </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../assets/qr/i/ class=md-nav__link> <span class=md-ellipsis> I </span> </a> </li> </ul> </nav> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_5 type=checkbox id=__nav_5> <label class=md-nav__link for=__nav_5> <span class=md-ellipsis> Checklists </span> <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label=Checklists data-md-level=1> <label class=md-nav__title for=__nav_5> <span class="md-nav__icon md-icon"></span> Checklists </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../checklists/clinical-allergen-challenge/ class=md-nav__link> <span class=md-ellipsis> Clinical Allergen Challenge Checklist </span> </a> </li> <li class=md-nav__item> <a href=../../checklists/methotrexate/ class=md-nav__link> <span class=md-ellipsis> Methotrexate </span> </a> </li> <li class=md-nav__item> <a href=../../checklists/rituximab/ class=md-nav__link> <span class=md-ellipsis> Rituximab Therapy </span> </a> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_6 type=checkbox id=__nav_6> <label class=md-nav__link for=__nav_6> <span class=md-ellipsis> Patient information </span> <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label="Patient information" data-md-level=1> <label class=md-nav__title for=__nav_6> <span class="md-nav__icon md-icon"></span> Patient information </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../patient-information/acute-urticaria/ class=md-nav__link> <span class=md-ellipsis> Acute Urticaria </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/alemtuzumab/ class=md-nav__link> <span class=md-ellipsis> Alemtuzumab </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/allergic-rhinitis/ class=md-nav__link> <span class=md-ellipsis> Allergic Rhinitis </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/anaphylaxis/ class=md-nav__link> <span class=md-ellipsis> Anaphylaxis </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/atopic-dermatitis/ class=md-nav__link> <span class=md-ellipsis> Atopic Dermatitis </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/avoiding-allergens/ class=md-nav__link> <span class=md-ellipsis> Avoiding Allergens </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/azathioprine/ class=md-nav__link> <span class=md-ellipsis> Azathioprine </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/chronic-urticaria/ class=md-nav__link> <span class=md-ellipsis> Chronic Urticaria </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/ciclosporin/ class=md-nav__link> <span class=md-ellipsis> Ciclosporin </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/clinical-allergen-challenge/ class=md-nav__link> <span class=md-ellipsis> Clinical Allergen Challenge </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/cvid/ class=md-nav__link> <span class=md-ellipsis> Common Variable Immune Deficiency (CVID) </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/cyclophosphamide-therapy/ class=md-nav__link> <span class=md-ellipsis> Cyclophosphamide Therapy </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/hydroxychloroquine/ class=md-nav__link> <span class=md-ellipsis> Hydroxychloroquine </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/immunoglobulin-replacement-therapy/ class=md-nav__link> <span class=md-ellipsis> Immunoglobulin Replacement Therapy </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/latex-allergy/ class=md-nav__link> <span class=md-ellipsis> Latex Allergy </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/methotrexate/ class=md-nav__link> <span class=md-ellipsis> Methotrexate </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/mycophenolate/ class=md-nav__link> <span class=md-ellipsis> Mycophenolate </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/omalizumab/ class=md-nav__link> <span class=md-ellipsis> Omalizumab </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/onj/ class=md-nav__link> <span class=md-ellipsis> Osteonecrosis of the Jaw (ONJ) </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/penicillin-allergy-testing/ class=md-nav__link> <span class=md-ellipsis> Penicillin Allergy Testing </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/prednisone/ class=md-nav__link> <span class=md-ellipsis> Prednisone </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/preparing-for-immunosuppression/ class=md-nav__link> <span class=md-ellipsis> Preparing for Immunosuppresion </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/risendronate/ class=md-nav__link> <span class=md-ellipsis> Risendronate (Actonel) </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/rituximab/ class=md-nav__link> <span class=md-ellipsis> Rituximab </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/sjogrens-syndrome/ class=md-nav__link> <span class=md-ellipsis> Sjögren’s Syndrome </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/sle/ class=md-nav__link> <span class=md-ellipsis> Systemic Lupus Erythematosus (SLE) </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/steroid-withdrawal/ class=md-nav__link> <span class=md-ellipsis> Steroid Withdrawal </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/steroids-and-osteoporosis/ class=md-nav__link> <span class=md-ellipsis> Steroids and Osteoporosis </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/subcutaneous-immunotherapy/ class=md-nav__link> <span class=md-ellipsis> Subcutaneous Immunoglobulin Therapy </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/tnf-inhibitors/ class=md-nav__link> <span class=md-ellipsis> Tumour Necrosis Factor (TNF) Inhibitors </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/wet-dressings/ class=md-nav__link> <span class=md-ellipsis> Wet Dressings </span> </a> </li> <li class=md-nav__item> <a href=../../patient-information/zolendronate/ class=md-nav__link> <span class=md-ellipsis> Zolendronate </span> </a> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--active md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_7 type=checkbox id=__nav_7 checked> <label class=md-nav__link for=__nav_7> <span class=md-ellipsis> Protocols </span> <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label=Protocols data-md-level=1> <label class=md-nav__title for=__nav_7> <span class="md-nav__icon md-icon"></span> Protocols </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../alutek-immunotherapy/ class=md-nav__link> <span class=md-ellipsis> Alutek Immunotherapy </span> </a> </li> <li class=md-nav__item> <a href=../anaphylaxis/ class=md-nav__link> <span class=md-ellipsis> Anaphylaxis </span> </a> </li> <li class=md-nav__item> <a href=../aspirin-desensitisation-rapid/ class=md-nav__link> <span class=md-ellipsis> Aspirin desensitisation rapid </span> </a> </li> <li class=md-nav__item> <a href=../aspirin-desensitisation/ class=md-nav__link> <span class=md-ellipsis> Aspirin Desensitisation Protocol </span> </a> </li> <li class=md-nav__item> <a href=../immunosuppression-screen/ class=md-nav__link> <span class=md-ellipsis> Immunosuppression Screen </span> </a> </li> <li class=md-nav__item> <a href=../offlabel-nmo-and-mg/ class=md-nav__link> <span class=md-ellipsis> Prescribing Rituximab Off-label for NMO and Myasthenia Patients </span> </a> </li> <li class=md-nav__item> <a href=../protocol-cyclophosphamide/ class=md-nav__link> <span class=md-ellipsis> Protocol for Pulsed IV Cyclophosphamide Immunosuppression </span> </a> </li> <li class=md-nav__item> <a href=../rituximab-infusion-protocol/ class=md-nav__link> <span class=md-ellipsis> Rituximab Infusion Protocols </span> </a> </li> <li class="md-nav__item md-nav__item--active"> <input class="md-nav__toggle md-toggle" data-md-toggle=toc type=checkbox id=__toc> <a href=./ class="md-nav__link md-nav__link--active"> <span class=md-ellipsis> Venom immunotherapy </span> </a> </li> <li class="md-nav__item md-nav__item--section md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_7_10 type=checkbox id=__nav_7_10> <label class=md-nav__link for=__nav_7_10> <span class=md-ellipsis> Drug allergy </span> <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label="Drug allergy" data-md-level=2> <label class=md-nav__title for=__nav_7_10> <span class="md-nav__icon md-icon"></span> Drug allergy </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../drug-allergy/penicillin-testing/ class=md-nav__link> <span class=md-ellipsis> Penicillin Testing Protocol </span> </a> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--section md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_7_11 type=checkbox id=__nav_7_11> <label class=md-nav__link for=__nav_7_11> <span class=md-ellipsis> Prednisone </span> <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label=Prednisone data-md-level=2> <label class=md-nav__title for=__nav_7_11> <span class="md-nav__icon md-icon"></span> Prednisone </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../prednisone/3monthschedule/ class=md-nav__link> <span class=md-ellipsis> Prednisone - 3-4 month weaning schedule </span> </a> </li> <li class=md-nav__item> <a href=../prednisone/reduced-dose-regimen-50to75kg/ class=md-nav__link> <span class=md-ellipsis> (50-75kg) Prednisone Reduced-dose Regimen </span> </a> </li> <li class=md-nav__item> <a href=../prednisone/reduced-dose-regimen-all/ class=md-nav__link> <span class=md-ellipsis> (All) Prednisone Reduced-dose Regimen </span> </a> </li> <li class=md-nav__item> <a href=../prednisone/reduced-dose-regimen-over50kg/ class=md-nav__link> <span class=md-ellipsis> (>75kg) Prednisone Reduced-dose Regimen </span> </a> </li> <li class=md-nav__item> <a href=../prednisone/reduced-dose-regimen-under50kg/ class=md-nav__link> <span class=md-ellipsis> (<50kg) Prednisone Reduced-dose Regimen </span> </a> </li> </ul> </nav> </li> </ul> </nav> </li> </ul> </nav> </div> </div> </div> <div class="md-sidebar md-sidebar--secondary" data-md-component=sidebar data-md-type=toc> <div class=md-sidebar__scrollwrap> <div class=md-sidebar__inner> <nav class="md-nav md-nav--secondary" aria-label="Table of contents"> </nav> </div> </div> </div> <div class=md-content data-md-component=content> <article class="md-content__inner md-typeset"> <h1 id=modified-rush-protocol-for-venom-immunotherapy>Modified Rush Protocol for Venom Immunotherapy<a class=headerlink href=#modified-rush-protocol-for-venom-immunotherapy title="Permanent link">&para;</a></h1> <p><strong>Venom immunotherapy (VIT)</strong>, is indicated for patients who have suffered a severe systemic allergic (anaphylactic) reaction following an insect sting and have had sensitivity confirmed by skin testing and/or venom specific IgE. VIT is available in NSW for honey bee (<em>Apis mellifera</em>), paper wasp (<em>Polistes</em>) and European wasp – also called yellow jacket (<em>Vespula germanica</em>) – collectively known as Hymenoptera Venom Immunotherapy.</p> <h1 id=aim>Aim<a class=headerlink href=#aim title="Permanent link">&para;</a></h1> <p>The aim of VIT is to reduce the risk of life threatening reaction to further stings in persons with a previous systemic reaction, and demonstrated venom-specific IgE-mediated sensitisation.</p> <h1 id=background>Background<a class=headerlink href=#background title="Permanent link">&para;</a></h1> <p>Hypersensitivity to insect stings are potentially life threatening. Since the potential for severe systemic reactions exists in the use of these products, the Hymenoptera venom preparations should be used</p> <ol> <li>by doctors experienced in administering immunotherapy</li> <li>under the guidance of a specialist Immunologist,</li> <li>only where adequate means for treating systemic reactions are immediately available.</li> <li>The patient should be fully informed of possible benefits and risks and should be closely observed.</li> </ol> <p>Before testing or treatment of patients with these products the doctor should be thoroughly familiar with all aspects of use of these products including indications, risks, contraindications and treatment of adverse reactions. Severe local or systemic reactions to venom administration can occur immediately (within one hour) or as delayed reactions. Patients should be kept under direct observation for a minimum of 30 minutes following skin testing and/or therapeutic injections, and should be instructed to contact the doctor promptly if symptoms of an allergic reaction or shock occur.</p> <h1 id=specific-issues>Specific issues<a class=headerlink href=#specific-issues title="Permanent link">&para;</a></h1> <h2 id=anaphylaxis-plan>Anaphylaxis plan<a class=headerlink href=#anaphylaxis-plan title="Permanent link">&para;</a></h2> <p>Patients should be instructed in the use of, and have available, an emergency anaphylaxis kit for self administration of adrenaline.</p> <h2 id=route-of-administration>Route of administration<a class=headerlink href=#route-of-administration title="Permanent link">&para;</a></h2> <p>Injections are subcutaneous and not intradermal or intravenous. Specific steps should be employed to prevent inadvertent IV administration</p> <h2 id=venom-dilutions>Venom dilutions<a class=headerlink href=#venom-dilutions title="Permanent link">&para;</a></h2> <p>An error in dilution of venom and labelling of reagents are common causes of ADR in VIT.</p> <h2 id=premedication>Premedication<a class=headerlink href=#premedication title="Permanent link">&para;</a></h2> <p>Pre-treatment with the H1 antihistamine terfenadine reduced VIT reactions (local and systemic) in randomized controlled trials. Routine anti-H1 premedication is recommended, although this may mask some features of systemic reactions.</p> <h2 id=baseline-tryptase>Baseline tryptase<a class=headerlink href=#baseline-tryptase title="Permanent link">&para;</a></h2> <p>Baseline tryptase level correlate with the risk of systemic reactions during VIT. Elevated levels may indicate an underlying hyperplastic mast cell disorders</p> <h2 id=batch-to-batch-variation>Batch to batch variation<a class=headerlink href=#batch-to-batch-variation title="Permanent link">&para;</a></h2> <p>New batches of venom require dose adjustment for initial safety in maintenance phase</p> <h2 id=dosing-protocols>Dosing protocols<a class=headerlink href=#dosing-protocols title="Permanent link">&para;</a></h2> <p>A variety of dosing protocols are used in different clinics. The terms rush and ultrarush have different meanings by different authors. Unless otherwise required, standard dosing strategies should follow the package insert. The &quot;Table2 – modified rush protocol&quot; in Up-to-date is a suitable protocol, and is used as the basis of the dosing strategy described below.</p> <p>A maintenance dose of 100 micrograms is chosen in most protocols and represents approximately twice the venom content of a standard honey-bee sting. This dose will not always be tolerated and may require individual patient adjustment. In one study a maintenance dose of 100 micrograms protected 96-100% of subjects on challenge, whereas a dose of 50 micrograms protected 79% of subjects.</p> <h2 id=interval-between-maintenance-injections>Interval between maintenance injections<a class=headerlink href=#interval-between-maintenance-injections title="Permanent link">&para;</a></h2> <p>Maintenance doses should be given at 4 weekly intervals for the first year. Various practice parameters allow for extending the interval to 6 weeks and even 8 weeks in subsequent years. Intervals of longer than 3 months between injections are not considered reliably protective.</p> <h2 id=local-reactions-to-vit>Local reactions to VIT<a class=headerlink href=#local-reactions-to-vit title="Permanent link">&para;</a></h2> <p>Occur in 50% of adults usually at doses of 20-30 micrograms. Local reactions are bothersome rather than dangerous, and do not predict future systemic reactions. Local reactions in most cases should not lead to adjustment of the treatment protocol as they generally do not persist with higher doses: &quot;treat through&quot;. Cold packs can be useful.</p> <h2 id=systemic-reactions-to-vit>Systemic reactions to VIT<a class=headerlink href=#systemic-reactions-to-vit title="Permanent link">&para;</a></h2> <p>Systemic reactions occur in 3-12% of cases, the majority being mild and easily treated. Premedication with anti-H1 agents reduces this risk, and high baseline serum tryptase levels and unstable asthma increase this risk - See above. Systemic reactions are more likely to occur in the dose escalation phase.</p> <h2 id=dose-adjustment-after-a-systemic-reaction>Dose adjustment after a systemic reaction<a class=headerlink href=#dose-adjustment-after-a-systemic-reaction title="Permanent link">&para;</a></h2> <p>Return in 1 week and administer half the implicated dose under anti-H1 premedication</p> <h2 id=measures-of-efficacy>Measures of efficacy<a class=headerlink href=#measures-of-efficacy title="Permanent link">&para;</a></h2> <p>There are no satisfactory tools to assess efficacy other than tolerance of insect stings in the field. Insect sting challenges are not used because they are impractical and lack standardisation. Venom specific IgG is used in some units but may not be available. Venom skin tests are not to be used as these may remain positive.</p> <h2 id=duration-of-therapy>Duration of therapy<a class=headerlink href=#duration-of-therapy title="Permanent link">&para;</a></h2> <p>The majority of patients will receive maintenance injections for a period of 5 years. Indefinite VIT is recommended for life threatening reactions where there is ongoing risk of sting exposure.</p> <h2 id=dosing-schedule>Dosing Schedule<a class=headerlink href=#dosing-schedule title="Permanent link">&para;</a></h2> <p>Injections 1, 2 and 3 are given at 30 minute intervals on days when more than one injection is administered. During weeks 1 through 3, the patient receives 3 injections per visit. During weeks 4 through 8, the patient receives two injections per visit. Maintenance is achieved by approximately week 8. Thereafter, the patient receives one injection per visit and the interval between visits is extended from weekly to monthly.</p> <h1 id=patient-education-and-information>Patient Education and Information<a class=headerlink href=#patient-education-and-information title="Permanent link">&para;</a></h1> <ul class=task-list> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> Immunotherapy patient information sheet</li> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> Insect allergy patient information sheet</li> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> Patient consent to treatment</li> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> Medic-Alert bracelet</li> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> Anaphylaxis action plan</li> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> Consider Epipen</li> </ul> <h1 id=vit-modified-rush-protocol-checklist>VIT – Modified Rush Protocol Checklist<a class=headerlink href=#vit-modified-rush-protocol-checklist title="Permanent link">&para;</a></h1> <h2 id=checklist-to-be-completed-prior-to-vit>Checklist to be completed prior to VIT<a class=headerlink href=#checklist-to-be-completed-prior-to-vit title="Permanent link">&para;</a></h2> <ul class=task-list> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> Patient is fully informed of risks, benefits, implications and limitations of VIT. This includes awareness that there is a risk that this challenge will bring about an allergic reaction. On very rare occasions, such an allergic reaction could be serious and require admission to hospital for observation.</li> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> Patient consent</li> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> Patient is clinically well with no acute illness.</li> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> Asthma well controlled.</li> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> Patient is not taking beta blockers.</li> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> Consideration of pre-medication with an anti-histamine</li> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> Negative pregnancy test for female patients</li> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> Base-line B/P and HR – documented on hospital observation chart</li> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> Base-line Peak Flow and Mallampati score – documented on hospital observation chart</li> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> IV access is obtained</li> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> Emergency resuscitation equipment and medication available</li> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> Dedicated staff member available throughout procedure</li> </ul> <h2 id=checklist-to-be-completed-at-discharge>Checklist to be completed at discharge<a class=headerlink href=#checklist-to-be-completed-at-discharge title="Permanent link">&para;</a></h2> <ul class=task-list> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> Sites reviewed and any reaction documented</li> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> Observations stable – B/P, HR, Peak Flow, Mallampati Score</li> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> Delayed reaction and Epipen education</li> <li class=task-list-item><label class=task-list-control><input type=checkbox disabled><span class=task-list-indicator></span></label> IVC removed</li> </ul> <h1 id=references>References<a class=headerlink href=#references title="Permanent link">&para;</a></h1> <p>Bonifazi,et al. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy 2005; 60: 1459-70</p> <p>Glerant, et al. Comparison of 2 maintenance doses (100µg vs. 200µg) in Hymenoptera venom immunotherapy: influence of the maintenance dose on the immunologic response. Annals of Allergy, Asthma &amp; Immunology 2005; 94: 451-6</p> <p>Lerch, et al. Long-term protection after stopping venom immunotherapy: results of re-stings in 200 patients. JACI 1998; 101: 606-12</p> <p>Muller, et al. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety. JACI 1992; 89: 529-35</p> <p>Rueff, et al. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased doses. JACI 2001; 108: 1027-32</p> <p>Tarhini, et al. Safety of venom immunotherapy administered by a cluster schedule. JACI 1992; 89(6): 1198-9</p> <p>Toogood. Risk of anaphylaxis in patients receiving beta-blocker drugs. JACI 1988; 81: 1-5</p> <p><strong>Typical conventional dosing schedules for venom immunotherapy: Schedule 2</strong></p> <table> <thead> <tr> <th>Week</th> <th>Injection 1</th> <th></th> <th>Injection 2</th> <th></th> <th>Injection 3</th> <th></th> </tr> </thead> <tbody> <tr> <td></td> <td>Concentration, micrograms/mL</td> <td>Volume, mL</td> <td>Concentration, micrograms/mL</td> <td>Volume, mL</td> <td>Concentration, micrograms/mL</td> <td>Volume, mL</td> </tr> <tr> <td>1</td> <td>0.01</td> <td>0.1</td> <td>0.1</td> <td>0.1</td> <td>1</td> <td>0.1</td> </tr> <tr> <td>2</td> <td>1</td> <td>0.1</td> <td>1</td> <td>0.5</td> <td>10</td> <td>0.1</td> </tr> <tr> <td>3</td> <td>10</td> <td>0.1</td> <td>10</td> <td>0.5</td> <td>10</td> <td>1</td> </tr> <tr> <td>4</td> <td>100</td> <td>0.1</td> <td>100</td> <td>0.2</td> <td>-</td> <td>-</td> </tr> <tr> <td>5</td> <td>100</td> <td>0.2</td> <td>100</td> <td>0.3</td> <td>-</td> <td>-</td> </tr> <tr> <td>6</td> <td>100</td> <td>0.3</td> <td>100</td> <td>0.3</td> <td>-</td> <td>-</td> </tr> <tr> <td>7</td> <td>100</td> <td>0.4</td> <td>100</td> <td>0.4</td> <td>-</td> <td>-</td> </tr> <tr> <td>8</td> <td>100</td> <td>0.5</td> <td>100</td> <td>0.5</td> <td>-</td> <td>-</td> </tr> <tr> <td>9</td> <td>100</td> <td>1</td> <td>-</td> <td>-</td> <td>-</td> <td>-</td> </tr> <tr> <td>Monthly</td> <td>100</td> <td>1</td> <td>-</td> <td>-</td> <td>-</td> <td>-</td> </tr> </tbody> </table> <p>Injections 1, 2, and 3 are given at 30 minute intervals on days when more than one injection is administered (reading from left to right across table in the week 1 row). During weeks 1 through 3, the patient receives three injections per visit. During weeks 4 through 8, the patient receives two injections per visit. Maintenance is achieved by approximately week 8. Thereafter, the patient receives one injection per visit and the interval between visits is extended from weekly to monthly. This schedule is based upon the package insert for ALK-Abello venom extracts (Round Rock, TX).</p> <p><em>Original figure modified for this publication. Reproduced with permission from: Golden DBK. Insect Allergy. In: Middleton&#39;s Allergy: Principles &amp; Practice, 7<sup>th</sup> ed, Adkinson NF Jr, Bochner BS, Busse WW, et al (Eds), Mosby Elsevier, Philadelphia 2009. Illustrations used with the permission of Elsevier Inc. All rights reserved.</em></p> <p>Graphic 64856 Version 8.0</p> <h1 id=brown-grading-system>Brown Grading System<a class=headerlink href=#brown-grading-system title="Permanent link">&para;</a></h1> <p><strong>Grading of Severity of Anaphylaxis</strong></p> <p>A grading system of severity of generalized hypersensitivity reactions has been developed to aid the definition of reaction severity in clinical practice and assist with treatment decisions. At the discretion of the medical officer,</p> <p>IM adrenaline is indicated for reactions of minimum Brown Grade II.</p> <p>Brown Grading System of Severity in Generalised Hypersensitivity Reactions (Ref 1)</p> <h2 id=i-mild>I – Mild<a class=headerlink href=#i-mild title="Permanent link">&para;</a></h2> <p>Erythema, urticaria, non-airway threatening angioedema</p> <h2 id=ii-moderate>II - Moderate<a class=headerlink href=#ii-moderate title="Permanent link">&para;</a></h2> <p>Dyspnoea, stridor, wheeze, dizziness, vomiting, sweating, chest/throat tightness, abdominal pain</p> <h2 id=iii-severe>III – Severe<a class=headerlink href=#iii-severe title="Permanent link">&para;</a></h2> <p>Cyanosis OR SaO2 ≤ 92% OR SBP \&lt; 90mmHg OR confusion, collapse, incontinence</p> <h1 id=anaphylaxis>Anaphylaxis<a class=headerlink href=#anaphylaxis title="Permanent link">&para;</a></h1> <p>Brown Grade II or III - see below</p> <ul> <li>ABC + Adrenaline</li> <li>0.5mg IM (0.5mL x 1:1000) q5-15mins into lateral thigh</li> <li>Call for assistance if required (MET 222)</li> <li>Oxygen</li> <li>Fluids: IV normal saline if hypotensive</li> </ul> <p><strong>Other measures:</strong> 1.Antihistamine: Cetirizine 10mg OR Phenergan 25mg IM/SLOW IV 2.Hydrocortisone: 200mg IV q6h 3.Salbutamol : nebulised 2.5-5mg 4.Ranitidine: 50mg SLOW IV 5.Glucagon: If on beta-blockers, 1-2mg IM/SLOW IV, infusion 10μg/min</p> <h2 id=anaphylaxis-adult>Anaphylaxis: Adult<a class=headerlink href=#anaphylaxis-adult title="Permanent link">&para;</a></h2> <p>Patient in extremis: IV Adrenaline infusion</p> <ol> <li>Adrenaline 1mg in 100mL saline: start at 0.5mL/kg/hr then titrate</li> <li>ICU, ECG, oximetry, BP monitoring</li> <li>Note risks associated with IV bolus Adrenaline</li> </ol> <h3 id=post-acute>Post-acute<a class=headerlink href=#post-acute title="Permanent link">&para;</a></h3> <ol> <li>Observation minimum 6 hours post Adrenaline</li> <li>Contact Immunology on-call if Adrenaline administered</li> <li>Early Serum tryptase level</li> <li>Epipen prescription and action plan - www.allergy.org.au</li> <li>Immunology follow-up 9767 6735</li> </ol> <h3 id=brown-grade>Brown Grade<a class=headerlink href=#brown-grade title="Permanent link">&para;</a></h3> <p><strong>I – Mild</strong> Skin manifestations, non-airway angioedema <strong>II – Moderate</strong> SOB, stridor, wheeze, dizziness, vomiting, sweating, chest/throat tightness, abdominal pain <strong>III – Severe</strong> Cyanosis or SaO2 ≤ 92% or SBP \&lt; 90mmHg or confusion, collapse, incontinence</p> </article> </div> </div> <a href=# class="md-top md-top--hidden md-icon" data-md-component=top> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8v12Z"/></svg> Back to top </a> </main> <footer class=md-footer> <nav class="md-footer__inner md-grid" aria-label=Footer> <a href=../rituximab-infusion-protocol/ class="md-footer__link md-footer__link--prev" aria-label="Previous: Rituximab Infusion Protocols" rel=prev> <div class="md-footer__button md-icon"> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg> </div> <div class=md-footer__title> <div class=md-ellipsis> <span class=md-footer__direction> Previous </span> Rituximab Infusion Protocols </div> </div> </a> <a href=../drug-allergy/penicillin-testing/ class="md-footer__link md-footer__link--next" aria-label="Next: Penicillin Testing Protocol" rel=next> <div class=md-footer__title> <div class=md-ellipsis> <span class=md-footer__direction> Next </span> Penicillin Testing Protocol </div> </div> <div class="md-footer__button md-icon"> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M4 11v2h12l-5.5 5.5 1.42 1.42L19.84 12l-7.92-7.92L10.5 5.5 16 11H4Z"/></svg> </div> </a> </nav> <div class="md-footer-meta md-typeset"> <div class="md-footer-meta__inner md-grid"> <div class=md-copyright> <div class=md-copyright__highlight> Copyright &copy; 2022 CRGH Department of Immunology </div> </div> <div class=md-social> <a href=https://liam.immunowiki.com target=_blank rel=noopener title=liam.immunowiki.com class=md-social__link> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 496 512"><!-- Font Awesome Free 6.1.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2022 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg> </a> <a href=https://liam.immunowiki.com target=_blank rel=noopener title=liam.immunowiki.com class=md-social__link> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 384 512"><!-- Font Awesome Free 6.1.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2022 Fonticons, Inc.--><path d="M66.4 322.5H16V0h50.4v322.5zM166.9 76.1h-50.4V512h50.4V76.1zm100.6 0h-50.4V512h50.4V76.1zM368 76h-50.4v247H368V76z"/></svg> </a> <a href=https://liam.immunowiki.com target=_blank rel=noopener title=liam.immunowiki.com class=md-social__link> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 640 512"><!-- Font Awesome Free 6.1.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2022 Fonticons, Inc.--><path d="M349.9 236.3h-66.1v-59.4h66.1v59.4zm0-204.3h-66.1v60.7h66.1V32zm78.2 144.8H362v59.4h66.1v-59.4zm-156.3-72.1h-66.1v60.1h66.1v-60.1zm78.1 0h-66.1v60.1h66.1v-60.1zm276.8 100c-14.4-9.7-47.6-13.2-73.1-8.4-3.3-24-16.7-44.9-41.1-63.7l-14-9.3-9.3 14c-18.4 27.8-23.4 73.6-3.7 103.8-8.7 4.7-25.8 11.1-48.4 10.7H2.4c-8.7 50.8 5.8 116.8 44 162.1 37.1 43.9 92.7 66.2 165.4 66.2 157.4 0 273.9-72.5 328.4-204.2 21.4.4 67.6.1 91.3-45.2 1.5-2.5 6.6-13.2 8.5-17.1l-13.3-8.9zm-511.1-27.9h-66v59.4h66.1v-59.4zm78.1 0h-66.1v59.4h66.1v-59.4zm78.1 0h-66.1v59.4h66.1v-59.4zm-78.1-72.1h-66.1v60.1h66.1v-60.1z"/></svg> </a> <a href=https://liam.immunowiki.com target=_blank rel=noopener title=liam.immunowiki.com class=md-social__link> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 512 512"><!-- Font Awesome Free 6.1.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2022 Fonticons, Inc.--><path d="M459.37 151.716c.325 4.548.325 9.097.325 13.645 0 138.72-105.583 298.558-298.558 298.558-59.452 0-114.68-17.219-161.137-47.106 8.447.974 16.568 1.299 25.34 1.299 49.055 0 94.213-16.568 130.274-44.832-46.132-.975-84.792-31.188-98.112-72.772 6.498.974 12.995 1.624 19.818 1.624 9.421 0 18.843-1.3 27.614-3.573-48.081-9.747-84.143-51.98-84.143-102.985v-1.299c13.969 7.797 30.214 12.67 47.431 13.319-28.264-18.843-46.781-51.005-46.781-87.391 0-19.492 5.197-37.36 14.294-52.954 51.655 63.675 129.3 105.258 216.365 109.807-1.624-7.797-2.599-15.918-2.599-24.04 0-57.828 46.782-104.934 104.934-104.934 30.213 0 57.502 12.67 76.67 33.137 23.715-4.548 46.456-13.32 66.599-25.34-7.798 24.366-24.366 44.833-46.132 57.827 21.117-2.273 41.584-8.122 60.426-16.243-14.292 20.791-32.161 39.308-52.628 54.253z"/></svg> </a> <a href=https://liam.immunowiki.com target=_blank rel=noopener title=liam.immunowiki.com class=md-social__link> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 448 512"><!-- Font Awesome Free 6.1.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2022 Fonticons, Inc.--><path d="M416 32H31.9C14.3 32 0 46.5 0 64.3v383.4C0 465.5 14.3 480 31.9 480H416c17.6 0 32-14.5 32-32.3V64.3c0-17.8-14.4-32.3-32-32.3zM135.4 416H69V202.2h66.5V416zm-33.2-243c-21.3 0-38.5-17.3-38.5-38.5S80.9 96 102.2 96c21.2 0 38.5 17.3 38.5 38.5 0 21.3-17.2 38.5-38.5 38.5zm282.1 243h-66.4V312c0-24.8-.5-56.7-34.5-56.7-34.6 0-39.9 27-39.9 54.9V416h-66.4V202.2h63.7v29.2h.9c8.9-16.8 30.6-34.5 62.9-34.5 67.2 0 79.7 44.3 79.7 101.9V416z"/></svg> </a> <a href=https://liam.immunowiki.com target=_blank rel=noopener title=liam.immunowiki.com class=md-social__link> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 448 512"><!-- Font Awesome Free 6.1.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2022 Fonticons, Inc.--><path d="M224.1 141c-63.6 0-114.9 51.3-114.9 114.9s51.3 114.9 114.9 114.9S339 319.5 339 255.9 287.7 141 224.1 141zm0 189.6c-41.1 0-74.7-33.5-74.7-74.7s33.5-74.7 74.7-74.7 74.7 33.5 74.7 74.7-33.6 74.7-74.7 74.7zm146.4-194.3c0 14.9-12 26.8-26.8 26.8-14.9 0-26.8-12-26.8-26.8s12-26.8 26.8-26.8 26.8 12 26.8 26.8zm76.1 27.2c-1.7-35.9-9.9-67.7-36.2-93.9-26.2-26.2-58-34.4-93.9-36.2-37-2.1-147.9-2.1-184.9 0-35.8 1.7-67.6 9.9-93.9 36.1s-34.4 58-36.2 93.9c-2.1 37-2.1 147.9 0 184.9 1.7 35.9 9.9 67.7 36.2 93.9s58 34.4 93.9 36.2c37 2.1 147.9 2.1 184.9 0 35.9-1.7 67.7-9.9 93.9-36.2 26.2-26.2 34.4-58 36.2-93.9 2.1-37 2.1-147.8 0-184.8zM398.8 388c-7.8 19.6-22.9 34.7-42.6 42.6-29.5 11.7-99.5 9-132.1 9s-102.7 2.6-132.1-9c-19.6-7.8-34.7-22.9-42.6-42.6-11.7-29.5-9-99.5-9-132.1s-2.6-102.7 9-132.1c7.8-19.6 22.9-34.7 42.6-42.6 29.5-11.7 99.5-9 132.1-9s102.7-2.6 132.1 9c19.6 7.8 34.7 22.9 42.6 42.6 11.7 29.5 9 99.5 9 132.1s2.7 102.7-9 132.1z"/></svg> </a> </div> </div> </div> </footer> </div> <div class=md-dialog data-md-component=dialog> <div class="md-dialog__inner md-typeset"></div> </div> <script id=__config type=application/json>{"base": "../..", "features": ["content.code.annotate", "navigation.indexes", "navigation.instant", "navigation.sections", "navigation.tabs", "navigation.top", "navigation.tracking", "search.highlight", "search.share", "search.suggest", "announce.dismiss", "content.tooltips"], "search": "../../assets/javascripts/workers/search.ec8bae80.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.config.lang": "en", "search.config.pipeline": "stopWordFilter", "search.config.separator": "[\\s\\-]+", "search.placeholder": "Search", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version.title": "Select version"}}</script> <script src=../../assets/javascripts/bundle.2f76aa63.min.js></script> </body> </html>